This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08361/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB08361/identifier/drugbank/
n7http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB08361/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08361/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB08361/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08361
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB08361 n14:DB08361
dcterms:title
2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide
adms:identifier
n9:9668647 n10:11493841 n11:99444832 n12:DB08361 n13:P5C
n3:IUPAC-Name
n4:271B50AF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B50B5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B50B4-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B50B1-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B50B2-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B50B3-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B50AD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B50AE-363D-11E5-9242-09173F13E4C5 n4:271B50AB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B50AC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B50BB-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B50BC-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B50B6-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B50B7-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B50B9-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B50B8-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B50BA-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B50C1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B50C3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B50C4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B50C0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B50BF-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B50C2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B50B0-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B50BD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B50BE-363D-11E5-9242-09173F13E4C5